12 April 2022 - Advice on three new medicines for use in conditions including a rare and fatal genetic condition affecting young children and a form of leukaemia has today been published by the Scottish Medicines Consortium.

An initial assessment report has been published for atidarsagene autotemcel (Libmeldy) which can be used to treat children with a rare genetic condition called metachromatic leukodystrophy.

Read SMC press release